Galen is pleased to announce the appointment of Johnny McGaughey as Vice President of Business Development, effective 1 October 2026.

The appointment represents an important milestone for Galen, recognising the role Business Development plays in supporting the company's continued growth and in developing partnerships and identifying new opportunities.

As Vice President of Business Development, Johnny McGaughey will secure and develop strategic partnerships, identify new portfolio opportunities and support the continued growth of Galen’s presence across the UK, Ireland, the Nordics, Germany and other international markets.

Welcoming the appointment, Dennise Broderick, President and Managing Director of Galen, said:

“I am delighted to congratulate Johnny on his appointment as Vice President of Business Development. This is an important milestone for Galen and reflects the increasingly important role Business Development plays in supporting our continued growth. Johnny brings a wealth of experience, strong industry relationships and a real understanding of our business, and I am confident that his leadership will help us build on our success, strengthen existing partnerships and identify new opportunities for Galen. I look forward to continuing to work with Johnny as he takes on this important new role and wish him every success.”

Commenting on his appointment, Johnny McGaughey said:

“I’m delighted to take on the role of Vice President of Business Development. Galen has exciting ambitions for the future, and Business Development has an important role to play in helping us realise them. I look forward to working closely with colleagues across Galen and POA, strengthening our existing partnerships, establishing new relationships and identifying development opportunities that support the continued growth of our business and our ability to make a meaningful difference.”

Galen works with partners internationally to identify opportunities that complement its portfolio and support its ambition to make a meaningful difference to patients and healthcare professionals.